There is new evidence for "giving up" statins

A recent review of 17 doctors from the United States, Ireland, Italy, Sweden, France and Japan said high or "bad" cholesterol levels were not linked to heart disease and asked doctors to "give up" statins.
, high levels of low-density lipoprotein cholesterol (LDL-C) have long been considered the leading cause of heart disease, one of the leading killers of heart disease.
, however, a new study based on data on about 1.3 million patients suggests that treating statins as the primary treatment for heart disease has "questionable benefits." The paper was recently published in
Journal of China.
article disputes some of his review reviews of statins, which the authors say are "based on misleading statistics that removed failed trials and ignored many conflicting observations." They also concluded that statins had many serious side effects and said they had been "minimized" by some trials.
authors include Sherif Sultan, a professor at the International Society of Vascular Surgery in Galway, Ireland, Dr. Malcolm Kendrick, author of The Great Stein Con, and Dr. David M Diamond, an American neuroscientist and cardiovascular researcher.
, author Professor Sherif Sultan says that despite unproven benefits and serious side effects, millions of people around the world are taking statins, including many without a history of heart disease.
"We recommend that clinicians abandon statins and PCSK-9 inhibitors and instead judge and treat the causes of cardiovascular disease." Sultan said. PCSK-9 inhibitors are a relatively new class of cholesterol-lowering treatments that are now widely available and cost around 20,000 euros a year.
the question of whether cholesterol-lowering treatments can reduce the risk of cardiovascular disease, the paper says new regulations proposed by health authorities in Europe and the United States in 2005 allow all trial data to be made public. The article showed that statin use in 12 European countries was not associated with reduced mortality between 2000 and 2012.
Also, experts found that in the general population, high "bad" cholesterol levels did not appear to be associated with a risk of cardiovascular disease, even for individuals with familial hypercholesterolemia, a genetic disorder characterized by high LDL-C levels.
authors say the benefits of using cholesterol-lowering drugs are questionable. They found that high total cholesterol was not associated with atherosclerosis (Atherosclerosis), and four studies confirmed a lack of association between LDL-C and atherosclerosis.
same time, they found that patients with acute myocardial infarction had lower-than-normal cholesterol levels, while healthy people with low "bad" cholesterol levels had a significantly increased risk of infectious diseases and cancer.
Sultan also presents one of the most striking findings, that older people with high LDL-C live longer.
for patients already at high risk of heart disease, experts agree that statins, especially those who have already had a heart attack or stroke, can be shown to be "lifeguards" and reduce the chance of a relapse.
, however, it is important to note that patients who have taken statins should continue to do so. If the patient has any concerns, consult a professional doctor. (Source: Wang Fei, China Science Daily)